ADMA Biologics Inc.

NASDAQ: ADMA · Real-Time Price · USD
16.95
-0.02 (-0.12%)
At close: Aug 15, 2025, 3:59 PM
17.00
0.29%
After-hours: Aug 15, 2025, 06:56 PM EDT

ADMA Biologics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
103.15M 51.35M 86.52M 51.09M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
5.66M 4.67M 4.77M 4.07M
Receivables
50M 27.42M 15.51M 28.58M
Inventory
170.24M 172.91M 163.28M 124.72M
Other Current Assets
8.03M 5.33M 5.1M n/a
Total Current Assets
331.41M 257.01M 270.4M 208.73M
Property-Plant & Equipment
63.34M 63.47M 68.75M 58.2M
Goodwill & Intangibles
3.99M 4.03M 4.54M 5.26M
Total Long-Term Assets
157.27M 72.17M 78.06M 67.52M
Total Assets
488.68M 329.18M 348.46M 276.25M
Account Payables
20.22M 15.66M 13.23M 12.43M
Deferred Revenue
143K 182K 142.83K 142.83K
Short-Term Debt
1.22M -182K n/a n/a
Other Current Liabilities
1.85M 2.91M 1.94M 16.05M
Total Current Liabilities
55.54M 49.81M 39.27M 30.38M
Long-Term Debt
72.34M 130.59M 142.83M 94.87M
Other Long-Term Liabilities
3.22M 2.11M 1.85M 397.35K
Total Long-Term Liabilities
84.12M 144.17M 157.22M 104.7M
Total Liabilities
139.66M 193.98M 196.49M 135.08M
Total Debt
82.12M 141.42M 154.44M 102.92M
Common Stock
24K 23K 22.18K 19.58K
Retained Earnings
-308.58M -506.26M -478.02M -412.11M
Comprehensive Income
n/a n/a -0.00 n/a
Shareholders Equity
349.02M 135.21M 151.97M 141.17M
Total Investments
n/a n/a n/a n/a